COMERICA BANK - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 189 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.50 and the average weighting 0.0%.

Quarter-by-quarter ownership
COMERICA BANK ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$5,690
+37.5%
1,0070.0%0.00%
Q1 2024$4,139
-5.0%
1,007
-2.4%
0.00%
Q4 2023$4,355
-2.3%
1,0320.0%0.00%
Q3 2023$4,458
+5844.0%
1,032
+23.7%
0.00%
-100.0%
Q2 2023$75
-70.9%
834
-97.5%
0.01%
+300.0%
Q4 2022$258
-99.9%
33,847
-21.9%
0.00%
-50.0%
Q3 2022$450,000
-18.9%
43,356
-9.8%
0.00%
-20.0%
Q2 2022$555,000
+3.4%
48,071
+0.8%
0.01%
+25.0%
Q1 2022$537,000
-21.3%
47,706
+2.5%
0.00%
-20.0%
Q4 2021$682,000
-60.4%
46,526
-54.6%
0.01%
-50.0%
Q3 2021$1,722,000
+115.8%
102,467
+97.1%
0.01%
+100.0%
Q2 2021$798,000
-15.1%
51,998
-6.1%
0.01%
-16.7%
Q1 2021$940,000
+15.1%
55,398
-3.7%
0.01%
+20.0%
Q4 2020$817,000
+39.7%
57,553
+0.9%
0.01%
+25.0%
Q3 2020$585,000
-5.8%
57,056
-0.1%
0.00%
-20.0%
Q2 2020$621,000
+0.6%
57,107
+10.5%
0.01%
-16.7%
Q1 2020$617,000
-5.2%
51,683
+3.2%
0.01%
+20.0%
Q4 2019$651,000
-5.1%
50,074
+0.1%
0.01%0.0%
Q3 2019$686,000
+4.1%
50,009
+0.8%
0.01%0.0%
Q2 2019$659,000
-29.0%
49,604
-4.3%
0.01%
-37.5%
Q1 2019$928,000
-36.4%
51,842
+1.4%
0.01%
-33.3%
Q4 2018$1,458,00051,1170.01%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 728,000$10,425,0005.01%
Signpost Capital Advisors, LP 828,793$11,868,0004.38%
Palo Alto Investors LP 3,786,908$54,229,0003.18%
RTW INVESTMENTS, LP 500,000$7,160,0002.65%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,139,787$59,282,0002.13%
First Light Asset Management, LLC 229,818$3,291,0001.86%
KINGDON CAPITAL MANAGEMENT, L.L.C. 2,461,305$35,246,0001.53%
PURA VIDA INVESTMENTS, LLC 175,000$2,506,0000.92%
WALL STREET ASSOCIATES 655,800$9,391,0000.90%
SPHERA FUNDS MANAGEMENT LTD. 368,390$5,275,0000.90%
View complete list of VANDA PHARMACEUTICALS INC shareholders